For the first time in 30 years, a new drug class known as the CGRP-Antagonists (calcitonin gene-related peptide) has emerged.

Neil Kiefer, CEO of the Florida-based Hooters founding group that's buying the company as part of a bankruptcy agreement, ...

The US Food and Drug Administration (FDA) has approved Click Therapeutics’ CT-132 as the first prescription digital ...

Migraine is a common neurological syndrome that affects approximately 10–20% of the population. The pathophysiology of migraine is unclear. 5-hydroxytriptamine is a key mediator in the ...

Atogepant, a new oral prescription drug, shows promise in preventing migraines by targeting CGRP receptors, reducing migraine ...

For various indications, the New York-based startup develops software ... Participants in the studies were already taking commonly prescribed migraine medications and they continued taking them ...

The software-based intervention aims to reduce brain hypersensitivity in patients with migraine by modulating responses to environmental and internal stimuli through a 12-week program.

New research is challenging assumptions that eating certain foods "cause" migraine attacks. So, what (and how) should people ...

Researchers have gained new insights into the basic biology of endometriosis ... The CGRP pathway is a target of several existing migraine medications, and when the team administered these drugs to ...

What Is New Daily Persistent Headache ... such as a head injury or migraines. Treatment for NDPH varies. There are many medications doctors can try, and they do help some people with this type ...

Migraine medications that are linked to congenital ... In addition, with the new lifestyle of caring for a newborn, there is decreased sleep, dehydration, and stress, which can trigger migraine ...

New-onset severe headaches later in life ... If you find yourself regularly taking acute migraine medications more than 10-15 days per month, you may be experiencing medication overuse headaches ...